CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-08 | Kramer Robert President and CEO | Shares withheld for taxes | −95 | $79.25 | $8K | 142,203 |
| 2020-05-08 | LINDAHL RICHARD S EVP, Chief Financial Officer | Shares withheld for taxes | −728 | $79.25 | $58K | 31,806 |
| 2020-05-05 | Richard Ronald Director | Sale | −8,375 | $80.19 | $672K | 8,020 |
| 2020-04-30 | El-Hibri Fuad Chairman | Sale | −20,000 | $74.01 | $1.5M | 1,229,523 |
| 2020-04-29 | El-Hibri Fuad Chairman | Sale | −20,000 | $74.24 | $1.5M | 1,249,523 |
| 2020-04-27 | Richard Ronald Director | Option exercise | +7,893 | $20.08 | $158K | 24,288 |
| 2020-04-27 | Richard Ronald Director | Sale | −7,893 | $78.00 | $616K | 16,395 |
| 2020-04-27 | Richard Ronald Director | Option exercise · Stock Options (Right to Buy) | −7,893 | $78.00 | $616K | 0 |
| 2020-04-23 | El-Hibri Fuad Chairman | Sale | −20,000 | $68.49 | $1.4M | 1,269,523 |
| 2020-04-22 | El-Hibri Fuad Chairman | Sale | −20,000 | $66.81 | $1.3M | 1,289,523 |
| 2020-04-20 | Havey Adam EVP, Business Operations | Option exercise | +17,009 | $30.86 | $525K | 51,265 |
| 2020-04-20 | Havey Adam EVP, Business Operations | Sale | −17,009 | $69.00 | $1.2M | 34,256 |
| 2020-04-20 | Havey Adam EVP, Business Operations | Sale · Stock Options (Right to Buy) | −17,009 | 80,384 | ||
| 2020-04-17 | Havey Adam EVP, Business Operations | Option exercise | +20,414 | $26.45 | $540K | 54,670 |
| 2020-04-17 | Havey Adam EVP, Business Operations | Sale | −20,414 | $65.00 | $1.3M | 34,256 |
| 2020-04-17 | Havey Adam EVP, Business Operations | Sale · Stock Options (Right to Buy) | −20,414 | 97,393 | ||
| 2020-04-16 | El-Hibri Fuad Chairman | Sale | −20,000 | $62.47 | $1.2M | 1,309,523 |
| 2020-04-15 | El-Hibri Fuad Chairman | Sale | −12,537 | $62.58 | $785K | 1,329,523 |
| 2020-04-14 | El-Hibri Fuad Chairman | Sale | −6,261 | $62.99 | $394K | 1,342,060 |
| 2020-04-13 | El-Hibri Fuad Chairman | Sale | −17,071 | $62.25 | $1.1M | 1,348,321 |
Page 25 of 31 · 601 trades